Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2026 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungenAcceptable Use
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to Reports
Fundraising

Anthropic

Anthropic Raises $2B in Series D

San Francisco, CAOctober 16, 20252 min read
Employees
500+

Anthropic Raises $2B in Series D


Anthropic has successfully raised $2B in a Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.


Company Overview


Anthropic is a AI/ML company headquartered in San Francisco, CA, founded in 2021 with 500+ employees.


AI safety company building Claude, large language models for enterprises


Fundraising Details


  • Amount Raised: $2B
  • Round Type: Series D
  • Valuation: $18B
  • Date: 2025-10-16
  • Investors: Menlo Ventures, Spark Capital, Google

About Anthropic


AI safety company building Claude, large language models for enterprises The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: San Francisco, CA
  • Founded: 2021
  • Team Size: 500+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Anthropic's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Anthropic's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $18B valuation marks an important milestone for Anthropic, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Anthropic is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-16. For more information about Anthropic, visit their headquarters at San Francisco, CA.

Company Info

Headquarters
San Francisco, CA
Founded
2021
Team Size
500+

Topics

Fundraising(2912)AI/ML(484)Series D(267)Anthropic

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free